Page last updated: 2024-08-25

chitosan and Infections, Orthomyxoviridae

chitosan has been researched along with Infections, Orthomyxoviridae in 22 studies

Research

Studies (22)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (4.55)	18.2507
2000's	2 (9.09)	29.6817
2010's	15 (68.18)	24.3611
2020's	4 (18.18)	2.80

Authors

Authors	Studies
Dhakal, S; Feliciano-Ruiz, N; Ghimire, S; Han, Y; Krakowka, S; Patil, V; Renu, S; Renukaradhya, GJ; Schrock, J	1
Acuña-Castillo, C; Barrera-Avalos, C; Escobar, A; Fernandez, R; Huidobro-Toro, JP; Imarai, M; Kogan, MJ; Matiacevich, S; Milla, LA; Pavez, J; Robles-Planells, C; Rojo, LE; Salas-Huenuleo, E; Sánchez-Guerrero, G; Spencer, E	1
Chaisuwirat, P; Ellison, D; Fernandez, S; Macareo, L; Midoeng, P; Rungrojcharoenkit, K; Sunintaboon, P; Ubol, S	1
Dhakal, S; Feliciano-Ruiz, N; Han, Y; Hanson, J; Krakowka, S; Patil, V; Ramesh, A; Renu, S; Renukaradhya, GJ; Schrock, J	1
Kim, EH; Kim, K; Lim, YT; Nguyen, TQ; Poo, H; Shim, SM; Sung, MH; Webby, R; Yang, J	1
Abdoli, A; Atyabi, F; Dinarvand, M; Esmailie, A; Jamali, A; Kheiri, MT; Mottaghitalab, F	1
Dhakal, S; Feliciano-Ruiz, N; Ghimire, S; HogenEsch, H; Hogshead, BT; Krakowka, S; Lee, CW; Lu, F; Renu, S; Renukaradhya, GJ; Shaan Lakshmanappa, Y	1
Abdoli, A; Abedi-Valugerdi, M; Alipour, S; Atyabi, F; Gholami, S; Jamali, A; Kheiri, MT; Sadati, SF; Soleymani, S	1
Fan, QZ; Ma, GH; Su, ZG; Wang, YQ; Wu, J; Yue, ZG; Zhou, M	1
Chaicumpa, W; Mitrevej, A; Mori, Y; Sawaengsak, C; Sinchaipanid, N; Srimanote, P; Yamanishi, K	1
Abnous, K; Bolourieh, T; Dehghan, S; Mazaheri, V; Tafaghodi, M; Tavassoti Kheiri, M; Torabi, A	1
Chen, J; Chen, Z; Li, C; Li, X; Liu, X; Qu, D; Sun, Z; Wang, H; Zheng, M	1
Chen, J; Chen, S; Chen, Z; Qu, D; Wang, F; Zhang, R; Zheng, D	1
Bao, Y; Wang, X; Wu, H; Wu, W; Zhou, D	1
Ashida, H; Itoh, M; Makimura, Y; Masui, A; Matahira, Y; Shibata, M; Umekawa, M; Umemura, M; Yamamoto, K; Yamazaki, K	1
de Jong, PH; Glansbeek, HL; Hagenaars, N; Heldens, JG; Hennink, WE; Jiskoot, W; Mastrobattista, E; Mooren, I; van den Bosch, H; Verheul, RJ	1
Chen, Q; Chen, Z; Sui, Z; Wang, H; Wu, R; Zhang, H; Zheng, M	1
Chen, Q; Chen, Z; Fang, F; Sui, Z; Zheng, M	1
Dixit, VK; Gupta, NK; Sharma, V; Tomar, P	1
Chen, Z; Dai, C; Ding, Y; Liu, F; Luo, J; Sun, B; Wang, H; Wang, X; Yi, Y; Zhang, T; Zhang, W; Zheng, D; Zheng, M	1
Choi, YK; Chowdhury, MY; Kim, CJ; Kim, JH; Lee, JS; Moon, HJ; Park, ME; Sung, MH; Talactac, MR	1
Il'ina, AV; Indulen, MK; Varlamov, VP; Zamiatina, NA	1

Other Studies

22 other study(ies) available for chitosan and Infections, Orthomyxoviridae

Article	Year
Poly(I:C) augments inactivated influenza virus-chitosan nanovaccine induced cell mediated immune response in pigs vaccinated intranasally. Veterinary microbiology, 2020, Volume: 242 Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Antibodies, Viral; Chitosan; Cytokines; Hemagglutination Inhibition Tests; Immunity, Cellular; Immunity, Innate; Influenza Vaccines; Nanoparticles; Orthomyxoviridae Infections; Poly I-C; Swine; Swine Diseases; Th1 Cells; Th2 Cells; Viral Load	2020
Chitosan-Based Nanoparticles for Intracellular Delivery of ISAV Fusion Protein cDNA into Melanoma Cells: A Path to Develop Oncolytic Anticancer Therapies. Mediators of inflammation, 2020, Volume: 2020 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chitosan; DNA, Complementary; Giant Cells; Humans; Isavirus; Lymphocytes; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nanomedicine; Nanoparticles; Oncolytic Virotherapy; Orthomyxoviridae Infections; Recombinant Fusion Proteins; Skin Neoplasms; Surface Properties; Transfection	2020
Development of an adjuvanted nanoparticle vaccine against influenza virus, an in vitro study. PloS one, 2020, Volume: 15, Issue:8 Topics: Adjuvants, Immunologic; Animals; Cell Line; Cells, Cultured; Chitosan; Dogs; Drug Carriers; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Madin Darby Canine Kidney Cells; Nanoparticles; Nucleocapsid Proteins; Orthomyxoviridae Infections; RNA-Binding Proteins; Viral Core Proteins	2020
Immunity and Protective Efficacy of Mannose Conjugated Chitosan-Based Influenza Nanovaccine in Maternal Antibody Positive Pigs. Frontiers in immunology, 2021, Volume: 12 Topics: Animals; Antibodies, Viral; Cells, Cultured; Chitosan; Dogs; Female; Immunity; Influenza Vaccines; Madin Darby Canine Kidney Cells; Mannose; Nanoparticles; Orthomyxoviridae Infections; Pregnancy; Swine; Swine Diseases; Vaccination; Vaccines, Inactivated	2021
Poly-γ-glutamic acid/chitosan nanogel greatly enhances the efficacy and heterosubtypic cross-reactivity of H1N1 pandemic influenza vaccine. Scientific reports, 2017, 03-21, Volume: 7 Topics: Adjuvants, Immunologic; Animals; Antigen Presentation; Antigens, Viral; Chitosan; Cross Reactions; Dendritic Cells; Disease Models, Animal; Ferrets; Histocompatibility Antigens Class I; Humans; Immunity, Cellular; Immunogenicity, Vaccine; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Mice; Orthomyxoviridae Infections; Phagosomes; Polyglutamic Acid	2017
Inhibiting influenza virus replication and inducing protection against lethal influenza virus challenge through chitosan nanoparticles loaded by siRNA. Drug delivery and translational research, 2018, Volume: 8, Issue:1 Topics: Animals; Chitosan; Chlorocebus aethiops; Female; Green Fluorescent Proteins; Humans; Influenza A Virus, H1N1 Subtype; Mice, Inbred BALB C; Nanoparticles; Nucleoproteins; Orthomyxoviridae Infections; RNA, Small Interfering; Vero Cells; Viral Core Proteins; Virus Replication	2018
Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs. Frontiers in immunology, 2018, Volume: 9 Topics: Administration, Intranasal; Animals; Antibodies, Viral; Antibody Specificity; Chitosan; Cytokines; Dendritic Cells; Immunity, Cellular; Immunity, Mucosal; Influenza Vaccines; Lymphocyte Activation; Nanoparticles; Orthomyxoviridae Infections; Swine; Swine Diseases; Vaccines, Inactivated; Virus Shedding	2018
Simultaneous formulation of influenza vaccine and chitosan nanoparticles within CpG oligodesoxi nucleotides leads to dose-sparing and protects against lethal challenge in the mouse model. Pathogens and disease, 2018, 11-01, Volume: 76, Issue:8 Topics: Adjuvants, Immunologic; Animals; Antibodies, Viral; Body Weight; Cell Proliferation; Chitosan; Cytokines; Disease Models, Animal; Drug Carriers; Enzyme-Linked Immunospot Assay; Female; Immunoglobulin G; Influenza Vaccines; Injections, Intradermal; Leukocytes, Mononuclear; Mice, Inbred BALB C; Nanoparticles; Oligodeoxyribonucleotides; Orthomyxoviridae Infections; Survival Analysis; Treatment Outcome; Vaccines, Inactivated	2018
Novel vaccine delivery system induces robust humoral and cellular immune responses based on multiple mechanisms. Advanced healthcare materials, 2014, Volume: 3, Issue:5 Topics: Animals; Antibodies, Viral; Chitosan; Drug Delivery Systems; Erythrocytes; Hemolysis; Humans; Hydrogels; Influenza A Virus, H5N1 Subtype; Influenza Vaccines; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Sheep	2014
Intranasal chitosan-DNA vaccines that protect across influenza virus subtypes. International journal of pharmaceutics, 2014, Oct-01, Volume: 473, Issue:1-2 Topics: Administration, Intranasal; Animals; Cell Line; Cell Survival; Chitosan; Dogs; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza Vaccines; Madin Darby Canine Kidney Cells; Mice, Inbred BALB C; Orthomyxoviridae Infections; Vaccines, DNA	2014
Rabbit nasal immunization against influenza by dry-powder form of chitosan nanospheres encapsulated with influenza whole virus and adjuvants. International journal of pharmaceutics, 2014, Nov-20, Volume: 475, Issue:1-2 Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Antibodies, Viral; Chitosan; Drug Carriers; Drug Compounding; Female; Immunity, Cellular; Immunity, Humoral; Immunity, Mucosal; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Nanospheres; Oligodeoxyribonucleotides; Orthomyxoviridae Infections; Powders; Quillaja Saponins; Rabbits; Vaccines, Inactivated	2014
Intranasal Administration of Chitosan Against Influenza A (H7N9) Virus Infection in a Mouse Model. Scientific reports, 2016, 06-29, Volume: 6 Topics: Administration, Intranasal; Animals; Chitosan; Immunity, Innate; Influenza A Virus, H7N9 Subtype; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections	2016
Influenza H7N9 LAH-HBc virus-like particle vaccine with adjuvant protects mice against homologous and heterologous influenza viruses. Vaccine, 2016, 12-12, Volume: 34, Issue:51 Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Antibodies, Viral; Chitosan; Cross Protection; Disease Models, Animal; Drug Carriers; Epitopes; Escherichia coli; Female; Hemagglutinin Glycoproteins, Influenza Virus; Hepatitis B Core Antigens; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H7N9 Subtype; Influenza Vaccines; Leukocytes, Mononuclear; Mice, Inbred BALB C; Orthomyxoviridae Infections; Recombinant Fusion Proteins; Vaccines, Synthetic; Vaccines, Virus-Like Particle	2016
Alkyl polyglycoside, a highly promising adjuvant in intranasal split influenza vaccines. Human vaccines & immunotherapeutics, 2017, 06-03, Volume: 13, Issue:6 Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Antibodies, Neutralizing; Antibodies, Viral; Chitosan; Disease Models, Animal; Female; Glycosides; Hemagglutination Inhibition Tests; Immunity, Mucosal; Immunoglobulin A; Immunoglobulin G; Influenza A Virus, H1N1 Subtype; Influenza B virus; Influenza Vaccines; Injections, Intramuscular; Lung; Mice, Inbred BALB C; Nasal Mucosa; Orthomyxoviridae Infections; Polymers; Polysaccharides, Bacterial; Survival Analysis; Treatment Outcome; Vaccines, Inactivated	2017
Design of a sialylglycopolymer with a chitosan backbone having efficient inhibitory activity against influenza virus infection. Journal of medicinal chemistry, 2008, Aug-14, Volume: 51, Issue:15 Topics: Cell Line; Chitosan; Drug Design; Glucose; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Models, Molecular; Molecular Structure; N-Acetylneuraminic Acid; Orthomyxoviridae Infections	2008
Relationship between structure and adjuvanticity of N,N,N-trimethyl chitosan (TMC) structural variants in a nasal influenza vaccine. Journal of controlled release : official journal of the Controlled Release Society, 2009, Dec-03, Volume: 140, Issue:2 Topics: Acetylation; Adjuvants, Immunologic; Administration, Intranasal; Animals; Antibodies, Viral; Chemistry, Pharmaceutical; Chitosan; Disease Models, Animal; Drug Compounding; Female; Immunization Schedule; Immunoglobulin A, Secretory; Immunoglobulin G; Influenza A virus; Influenza Vaccines; Methylation; Mice; Mice, Inbred C57BL; Molecular Structure; Nasal Lavage Fluid; Orthomyxoviridae Infections; Structure-Activity Relationship; Time Factors; Vaccines, Inactivated	2009
Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant. Archives of virology, 2010, Volume: 155, Issue:4 Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Antibodies, Viral; Body Weight; Chitosan; Cross Protection; Escherichia coli; Female; Gene Expression; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H5N1 Subtype; Influenza A Virus, H9N2 Subtype; Influenza Vaccines; Lung; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Survival Analysis; Viral Load; Viral Matrix Proteins	2010
Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant. Vaccine, 2010, Nov-10, Volume: 28, Issue:48 Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Antibodies, Viral; Antibody Formation; Chitosan; Cross Protection; Escherichia coli; Female; Immunity, Cellular; Immunization, Passive; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H5N1 Subtype; Influenza A Virus, H9N2 Subtype; Influenza Vaccines; Interferon-gamma; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Vaccines, Subunit; Viral Matrix Proteins	2010
Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza. Vaccine, 2011, Nov-08, Volume: 29, Issue:48 Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Antibodies, Viral; Chitosan; Female; Hemagglutination Inhibition Tests; Hemagglutinin Glycoproteins, Influenza Virus; Immunity, Cellular; Immunity, Humoral; Immunity, Mucosal; Immunoglobulin G; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Interferon-gamma; Interleukin-4; Mice; Mice, Inbred BALB C; Nanoparticles; Orthomyxoviridae Infections; Polyesters	2011
Intranasal immunization with live attenuated influenza vaccine plus chitosan as an adjuvant protects mice against homologous and heterologous virus challenge. Archives of virology, 2012, Volume: 157, Issue:8 Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Antibodies, Viral; Chitosan; Cross Protection; Female; Influenza Vaccines; Interferon-gamma; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Vaccination; Vaccines, Attenuated	2012
Mucosal immunization with recombinant influenza hemagglutinin protein and poly gamma-glutamate/chitosan nanoparticles induces protection against highly pathogenic influenza A virus. Veterinary microbiology, 2012, Dec-07, Volume: 160, Issue:3-4 Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Antibodies, Viral; Chitosan; Female; Hemagglutinin Glycoproteins, Influenza Virus; Immunity, Cellular; Immunity, Mucosal; Immunization; Immunoglobulin Isotypes; Influenza A Virus, H5N1 Subtype; Influenza Vaccines; Mice; Mice, Inbred BALB C; Nanoparticles; Orthomyxoviridae Infections; Polyglutamic Acid; Vaccines, Synthetic	2012
[The antiviral action of a modified bacterial ribonuclease]. Nauchnye doklady vysshei shkoly. Biologicheskie nauki, 1992, Issue:4 Topics: Animals; Antiviral Agents; Bacillus; Brachyura; Chitin; Chitosan; Drug Combinations; Drug Evaluation, Preclinical; Influenza A virus; Influenza B virus; Mice; Orthomyxoviridae Infections; Ribonucleases; Sindbis Virus	1992